BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Biologics

GHIT Fund Commits JPY 1.39 Billion To Back Six R&D Programmes Across Malaria, Tuberculosis And Neglected Tropical Diseases

The Global Health Innovative Technology (GHIT) Fund announced a total investment of approximately JPY 1.39 billion (USD 8.8 million1) in six R&D projec...

February 04, 2026 | News

WuXi Biologics Partners With Vertex To Advance Trispecific T Cell Engager For Autoimmune Diseases

WuXi Biologics (2269. HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), announced that it has signed a license ...

February 04, 2026 | News

Monash Innovation Labs And Agilent Technologies Australia Deepen Applied Research Partnership

Monash Innovation Labs and Agilent Technologies Australia have formalised a new partnership to embed advanced analytical instrumentation wit...

February 03, 2026 | News

MicuRx Pharmaceuticals Receives FDA IND Clearance For MRX 5 In Mycobacterium abscessus Pulmonary Disease

MicuRx Pharmaceuticals, Inc. ("MicuRx"), a clinical-stage biopharmaceutical company focused on developing novel anti-infective therapies for drug-resistant...

February 03, 2026 | News

AstraZeneca Commits $15 Billion Investment To Expand R&D And Manufacturing Footprint In China Through 2030

Landmark investment will expand AstraZeneca’s capabilities to discover, develop, and manufacture transformative new treatments in China In...

February 03, 2026 | News

Merck Strengthens India As A Strategic Healthcare R&D Growth Engine With New Innovation Hub

A workplace designed for long-term growth, efficiency, and innovation Elevating Merck Healthcare’s R&D India Hub as a premier talent powerho...

February 02, 2026 | News

Kazia Therapeutics Advances First In Class Nuclear PD L1 Protein Degrader With Compelling Preclinical Evidence

Kazia Therapeutics (NASDAQ: KZIA), an oncology-focused pharmaceutical company developing novel therapies for difficult-to-treat cancers, announced co...

February 02, 2026 | News

Azenta Life Sciences Expands Low DNA Binding Consumables To Support Sensitive NGS Workflows

Azenta Life Sciences offers a range of low binding consumables that deliver consistent performance from sensitive applications tha...

February 02, 2026 | News

Samsung Biologics Earns EcoVadis Platinum Sustainability Rating

Samsung Biologics (KRX: 207940.KS), a leading contract development and manufacturing organization (CDMO), announced that it has received the EcoVadis...

January 30, 2026 | News

Telix Pharmaceuticals Limited Doses First Patient In Japan Phase 3 Study Of Illuccix For Prostate Cancer Imaging

Telix Pharmaceuticals Limited announces that the first patient has been dosed in the Phase 3 registration study of TLX591-Px (Illuccix®, Kit for ...

January 30, 2026 | News

Nona Biosciences Joins Launch Of Innovative Alliance For Translational Medicine In Immunological Diseases

Nona Biosciences participated in the launch of the "Innovative Alliance for Translational Medicine in Immunological Diseases" (the "Alliance") and attended...

January 30, 2026 | News

Drug Farm Secures FDA Fast Track Designation For First In Class ALPK1 Inhibitor DF 003 In ROSAH Syndrome

Drug Farm, a clinical-stage biopharmaceutical company advancing two novel small molecule drugs for ROSAH syndrome and hepatitis B, announced that the U.S. ...

January 30, 2026 | News

Simcere Pharmaceutical Group Licenses First In Class TL1A IL23p19 Bispecific Antibody To Boehringer Ingelheim For Inflammatory Bowel Disease

Novel TL1A/IL23p19 bispecific antibody targets drivers of disease pathogenesis to overcome the efficacy ceiling in inflammatory bowel disease. Lice...

January 29, 2026 | News

Kazia Therapeutics Reports Encouraging Early Responses For Paxalisib Combination In Advanced Triple Negative Breast Cancer

Kazia Therapeutics provided a clinical update from its ongoing Phase 1b study evaluating paxalisib in combination with pembrolizumab and chemothe...

January 29, 2026 | News

Stay Connected